The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $169.48

Today's change-0.06 -0.04%
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $169.48

Today's change-0.06 -0.04%
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down slightly

Illumina Inc closed down just (U.S.)$0.06 Thursday to (U.S.)$169.48. Over the last five days, shares have lost 1.68% and are down 11.70% for the last year to date. This security has underperformed the S&P 500 by 26.95% during the last year.

Key company metrics

  • Open(U.S.) $170.12
  • Previous close(U.S.) $169.54
  • High(U.S.) $173.41
  • Low(U.S.) $167.35
  • Bid / Ask(U.S.) $169.48 / (U.S.) $219.93
  • YTD % change-11.70%
  • Volume603,012
  • Average volume (10-day)1,469,895
  • Average volume (1-month)1,214,535
  • Average volume (3-month)1,394,918
  • 52-week range(U.S.) $127.10 to (U.S.) $213.27
  • Beta0.73
  • Trailing P/E58.26×
  • P/E 1 year forward48.02×
  • Forward PEG3.01×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.91
Updated August 25 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.24%

Based on its net profit margin of 18.24%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.03%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 03, 201607/03/2016Apr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015
Revenue600572592550
Total other revenue--------
Total revenue600572592550
Gross profit424397410388
Total cost of revenue176175181163
Total operating expense438450448409
Selling / general / administrative149149147137
Research & development12512411499
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-112511
Other operating expenses, total--------
Operating income162121144141
Interest income (expense), net non-operating-8-9-7-13
Gain (loss) on sale of assets--------
Other--------
Income before tax157116135129
Income after tax11687103116
Income tax, total41283213
Net income12090104118
Total adjustments to net income--------
Net income before extra. items12090104118
Minority interest4223
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items12090104118
Inc. avail. to common incl. extra. items12090104118
Diluted net income12090104118
Dilution adjustment--------
Diluted weighted average shares148148149150
Diluted EPS excluding extraordinary itemsvalue per share0.810.600.700.79
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.760.620.730.85